UNMET CARE PERCEPTIONS OF INTENSIVE CARE NURSES

August 13, 2024 updated by: Dilek KIYMAZ, Ondokuz Mayıs University

UNMET NURSING CARE PERCEPTIONS OF INTENSIVE CARE NURSES: A QUALITATIVE STUDY

This study was conducted to determine the perceptions of intensive care nurses regarding unmet care. A qualitative descriptive approach. The study was completed between April and September 2023 by conducting semi-structured individual interviews with 20 intensive care nurses in a Training and Research Hospital in Turkey and analyzed using the inductive content analysis method.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

Unmet nursing care may occur due to systemic, institutional or nursing-related reasons. Reasons such as insufficient staff and equipment, excessive workload (Pereira et al., 2020), confusion between disciplines, and failure to prioritize care play an important role in missed care (Chaboyer et al., 2021; Dutra & Guirardello, 2021; Kılıç et al., 2023). In summary, while improvements should be made in nursing care practices to ensure patient safety and quality of care, systemic improvements should also be made. In order to make these improvements, it should be determined what the missed nursing care experienced and perceived in the clinical field is and what causes them. This research was conducted to determine the perceptions of intensive care nurses about unmet nursing care. This study is a qualitative design research conducted with intensive care nurses. In the study, a purposeful sample selection was made in accordance with the qualitative research approach. The number of participants was determined according to data saturation and is based on the volunteering of a total of 20 intensive care nurses. During the interview, the participants were asked a personal information form and expert opinion on the subject, as well as in-depth interview questions in a semi-structured information form consisting of eight questions.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Atakum
      • Samsun, Atakum, Turkey, 55100
        • Ondokuz Mayıs University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

This study comprised research with qualitative design completed with intensive care nurses.

Description

Inclusion Criteria:

  • working in intensive care
  • volunteering to participate in the study

Exclusion Criteria:

  • not volunteering to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
What is the perception of care among intensive care nurses?
Time Frame: April-September 2023
This study is a qualitative design study conducted with intensive care nurses. In the study, a purposeful sampling method was used in accordance with the qualitative research approach. The number of participants was determined according to data saturation and was based on the voluntary participation of a total of 20 intensive care nurses. During the interview, participants were asked to fill out a personal information form and expert opinions on the subject, as well as in-depth interview questions in a semi-structured information form consisting of eight questions. Data were collected through face-to-face individual interviews with nurses working in the intensive care unit of a Training and Research Hospital between April and September 2023. In-depth interview questions were prepared in line with literature knowledge and expert opinions were obtained.
April-September 2023
What are the thoughts of intensive care nurses regarding the perception of unmet care?
Time Frame: April-September 2023
After the interviews were completed, the raw data were manually transcribed by the researchers. The content analysis method was used in the evaluation of the data. The data were read several times by the researchers and codes were created from each word, sentence and paragraph. The analysis of the data was carried out manually using the level coding system and themes were created. Level coding was applied as open coding (first level), selective coding (second level), themes (third level) (Yıldırım & Şimşek 2016). After this stage, the relevant codes were classified and themes and sub-themes were created (Elo & Kyngäs, 2008; Vaismoradi et al., 2013).
April-September 2023

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Ondokuz Mayıs University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 1, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 30, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 30, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 7, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 13, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 16, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 16, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 13, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • UNMET NURSING CARE PERCEPTIONS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings